1-3 of 3
Soken-Nakazawa J. Song
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Suppressing Hepcidin By Tocilizumab Effectively Improve Anemia in Inflammatory Diseases: Clinical Evidence and Basic Mechanisms

Kazuyuki Yoshizaki, Soken-Nakazawa J Song, Hiroshi Kawabata
Journal: Blood
Blood (2014) 124 (21): 4006.
https://doi.org/10.1182/blood.V124.21.4006.4006
Published: 2014
Journal Articles

Analysis Of The Molecular Mechanisms Leading To Significantly Higher Serum Hepcidin and More Severe Anemia In Multicentric Castleman’s Disease (MCD) Patients Than In Rheumatoid Arthritis (RA) Patients

Soken-Nakazawa J. Song, MD, PhD, Hiroshi Kawabata, MD, PhD, Kazuyuki Yoshizaki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2181.
https://doi.org/10.1182/blood.V122.21.2181.2181
Published: 2013
Journal Articles

Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

Clinical Trials & Observations
Soken-Nakazawa J. Song, Naohisa Tomosugi, Hiroshi Kawabata, Takayuki Ishikawa, Teppei Nishikawa, Kazuyuki Yoshizaki
Journal: Blood
Blood (2010) 116 (18): 3627–3634.
https://doi.org/10.1182/blood-2010-03-271791
Published: 2010
Includes: Supplemental data